Characterization of daunorubicin resistance in K562 leukemia cells lacking daunorubicin reductase activity
- 1 September 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (9) , 1329-1336
- https://doi.org/10.1016/0277-5379(87)90116-7
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Contribution of drug transport and reductases to daunorubicin resistance in human myelocytic cellsCancer Chemotherapy and Pharmacology, 1986
- Comparative uptake, retention and cytotoxicity of daunorubicin by human myeloid cellsBiochemical Pharmacology, 1986
- Comparison of doxorubicin-induced DNA damage in doxorubicin-sensitive and -resistant P388 murine leukemia cellsInternational Journal of Cancer, 1986
- Uptake and metabolism of daunorubicin by human myelocytic cellsCancer Chemotherapy and Pharmacology, 1985
- Daunorubicin accumulation by human myeloblasts varying in anthracycline resistanceCancer Letters, 1984
- Cross resistance and cellular uptake of 4′-O-methyldoxorubicin in experimental tumors with acquired resistance to doxorubicinCancer Chemotherapy and Pharmacology, 1981
- Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemiaBiochemical Pharmacology, 1978
- A Film Detection Method for Tritium‐Labelled Proteins and Nucleic Acids in Polyacrylamide GelsEuropean Journal of Biochemistry, 1974
- Active outward transport of daunomycin in resistant ehrlich ascites tumor cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1973
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970